Fate Therapeutics Target Price

Where could FATE trade next? Consensus target price: $5.6.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.42

Average Target Price

$5.63

132.4% upside

4 analysts in the last 4 months

High: $8 | Low: $3.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-14	Piper Sandler	$8	230.6% upside
2026-08-14	Wells Fargo	$3.5	44.6% upside
2026-06-08	H.C. WainwrightDebjit Chattopadhyay	$7	189.3% upside
2026-05-19	Jefferies	$4	65.3% upside
2025-03-06	Stifel Nicolaus	$3	24% upside
2024-11-13	BMO CapitalEtzer Darout	$5	106.6% upside
2024-08-14	Stifel NicolausBenjamin Burnett	$5	106.6% upside
2024-06-17	Piper SandlerEdward Tenthoff	$6	147.9% upside
2024-05-16	H.C. WainwrightDebjit Chattopadhyay	$5	106.6% upside
2024-05-10	Piper SandlerEdward Tenthoff	$4	65.3% upside
2024-05-10	BMO CapitalEtzer Darout	$6	147.9% upside
2024-05-10	Canaccord GenuityBill Maughan	$9	271.9% upside
2023-01-09	Goldman Sachs	$4	65.3% upside
2023-01-06	Morgan Stanley	$8	230.6% upside
2023-01-06	Piper Sandler	$12	395.9% upside
2023-01-06	BMO Capital	$7	189.3% upside
2023-01-05	Truist FinancialRobyn Karnauskas	$7	189.3% upside
2022-12-15	Goldman SachsAndrea Tan	$10	313.2% upside
2022-12-13	Truist Financial	$46	1800.8% upside
2021-12-13	OppenheimerMatthew Biegler	$135	5478.5% upside
2021-11-08	CitigroupYigal Nochomovitz	$87	3495% upside
2021-11-05	Roth CapitalAnthony Butler	$60	2379.3% upside
2021-10-25	JefferiesMichael Yee	$145	5891.7% upside
2021-08-20	Piper SandlerEdward Tenthoff	$113	4569.4% upside

Fate Therapeutics (FATE) FAQ

Fate Therapeutics posts a target price of $5.6. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $5.6 for FATE means covering analysts, on average, see the stock 132.4% upside of $2.42 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for FATE's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fate Therapeutics's other metric pages and overview cover the third.

Judging Fate Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $5.6 here, then scan peer and history charts to see if the gap is persistent.